MACS® Immuno-Oncology Days

IMCB-Miltenyi Biotec Joint Symposium in Singapore 2019

Advances in immuno-oncology: 
Engaging new mechanisms for next generation cancer care

Thursday, July 4, 2019
09:30 a.m.–03:30 p.m. 
Biopolis Matrix Level 4, Exploration Theatrette, Singapore

Attendance is free of charge. 
Please register online here.

 

Chair: 
John Connolly, Ph.D.
Senior Principal Investigator and Director for Translational Immunology
Institute of Molecular and Cell Biology, A*STAR, Singapore

Agenda

09:20 a.m.Breakfast and registration 
09:50 a.m.Opening and welcome by John Connolly
10:00 a.m.Cytokine communication in inflammation and cancer: the T cell–phagocyte interface
Burkhard Becher, Ph.D.
Chariman, Institute of Experimental Immunology
University of Zurich, Switzerland
10:30 a.m.Personalized TCR T cell therapy for HBV-related hepatocellular carcinoma
Anthony Tanota Tan, Ph.D.                                                                             
Senior Research Fellow
Duke-NUS Medical School, Singapore
11:00 a.m.Chimeric Antigen Receptor (CAR) T cells targeting TIM-3 to treat acute myeloid leukemia
Wang Cheng-I, Ph.D. 
Principal Investigator
Singapore Immunology Network, Singapore  
11:30 a.m.Lights, microscope, and action
Ng Lai Guan, Ph.D.
Principle Investigator
Singapore Immunology Network, Singapore 
12:00 p.m.Lunch and network
01:30 p.m.Chimeric antigen receptor (CAR) T cell therapy: an overview and update
Soh Shui Yen, MBBS, MRCPCH (UK)
Head and Senior Consultant, Pediatric Hematology/Oncology Service, KK Women’s and Children’s Hospital, SingHealth, Singapore
02:00 p.m.Clinical results of a first-in-human phase 1 study of point of care manufactured bispecific anti-CD19, anti-CD20 chimerism antigen receptor modified (LV20.19CAR) T cells for relapsed, refractory, non-Hodgkin lymphoma
Nirav Shah, M.D., MSHP
Medical College of Wisconsin, Milwaukee, WI, USA
02:30 p.m.TBA
John Connolly, Ph.D.
Senior Principal Investigator and Director for Translational Immunology
Institute of Molecular and Cell Biology, A*STAR, Singapore
03:00 p.m.Panel discussion
03:30 p.m.Closing remarks